|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| 7th Anti-Bacterial World Summit | ||||||||||||||||
| December 31, 2002 | ||||||||||||||||
|
Strategic Research Institute, Hyatt Regency Princeton - Princeton, NJ 24-25 March 2003 Why is Big Pharma Getting Out of Anti-Bacterial Research? …And Why is Little Pharma Staying In? Resistance in Fluroquinolones: Mechanisms and Epidemiology Histidine Kinase–Mediated Signal Transduction Systems as Target for Therapeutic Intervention Marine Microbes: The Next Generation of Pharmaceutical Chemists etc... |
||||||||||||||||
| Organized by: | Mark Alexay/Jon Liong | |||||||||||||||
| Invited Speakers: | Abbott Laboratories Affinnium Arpida AG Cetek Corporation Chiron Corporation Cumbre Enanta Pharmaceuticals Essential Therapeutics Genome Therapeutics Genesoft Pharmaceuticals Johnson & Johnson PRI NewBiotics Nereus Pharmaceuticals Novozymes Biotech Quorex Rib-X Sequella Versicor Wyeth-Ayerst Research Hartford Hospital Massachusetts General Hospital The Scripps Research Institute |
|||||||||||||||
| Deadline for Abstracts: | www.srinstitute.com/cs246 | |||||||||||||||
| Registration: | www.srinstitute.com/cs246 | |||||||||||||||
| E-mail: | jliong@srinstitute.com | |||||||||||||||
| Posted by: | Adele Carfi | |||||||||||||||
| Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||